|
|
|
|
|
Doxorubicin hydrochloride |
|
Doxorubicin hydrochloride 99% Orange-Red Crystalline Powder |
|
25316-40-9 |
|
Used as an antineoplastic. Strong fluorescent dye intercalating into DNA. Antitumour antibiotic. Effect of adriamycin on heart mitochondrial DNA. Inhibitor of reverse transcriptase and RNA polymerase immunosuppressive agent.
|
|
Product Name: Doxorubicin hydrochloride Synonyms: Doxorubicin, HCl (8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1) (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1) Doxorubicin HCL CAS: 25316-40-9 MF: C27H30ClNO11 MW: 579.98 EINECS: 246-818-3 Assay: 99% Package: 25kg/carton Appearance: Orange-Red Crystalline Powder Usage Used as an antineoplastic. Strong fluorescent dye intercalating into DNA. Antitumour antibiotic. Effect of adriamycin on heart mitochondrial DNA. Inhibitor of reverse transcriptase and RNA polymerase immunosuppressive agent.
Others: Antibiotic and Antimicrobial Agents Lincomycin Hcl 859-18-7 Clindamycin HCl 21462-39-5 Clindamycin Phosphate 24729-96-2 Clindamycin Palmitate HCL 25507-04-4 Erythromycin 114-07-8 Erythromycin thiocyanate 7704-67-8 Erythromycin Estolate 3521-62-8 Roxithromycin 80214-83-1 Griseofulvin 126-07-8 Tetracycline HCL 64-75-5 Chloramphenicol 56-75-7 Metronidazole 443-48-1 Trimethoprim (TMP) 738-70-5 Cloxacillin Sodium 7081-44-9 Ampicillin Sodium 69-52-3 Ofloxacin Fluconazole 86386-73-4 Ketoconazole 65277-42-1 Clotrimazole 23593-75-1 Miconazole Nitrate 22832-87-7 Econazole Nitrate 24169-02-6 Chlorhexidine Acetate 56-95-1
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|